Activin A as a critical mediator of capillary formation: Interaction with the fibroblast growth factor action

Endocrine Journal

Volumn 54, Issue 2, 2007, Pages 311-318

  Hayashi, Yoshiro ^a,b   Maeshima, Kyoko ^a,b   Goto, Fumio ^a   Kojima, Itaru ^b  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Activin A; Angiogenesis; FGF 2; Tubulogenesis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVIN A; ACTIVIN RECEPTOR 2; COLLAGEN GEL; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FOLLISTATIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RECOMBINANT FIBROBLAST GROWTH FACTOR; SMAD7 PROTEIN;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; CAPILLARY; CONTROLLED STUDY; COW; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; EPITHELIUM CELL; MEDIATOR; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION;

ACTIVIN RECEPTORS, TYPE II; ACTIVINS; ANIMALS; AORTA; CAPILLARIES; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; FLAVONOIDS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECOMBINANT PROTEINS; SMAD7 PROTEIN; TRANSFECTION;

EID: 34249106182     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K06-222     Document Type: Article

References (21)

1. Mather JP, Moore A, Li RH (1997) Activins inhibins and follistatin: Further thoughts on growing family of regulators. Proc Soc Exp Biol Med 215: 209-222.
2. Ying SY, Zhang Z, Purst B, Batres Y, Huang G, Guangwu L (1997) Activins and inhibins and activin receptors in cell growth. Proc Soc Exp Biol Med 214: 114-122.
3. Ball EMA, Risbridger GP (2001) Activins as regulator of branching morphogenesis. Dev Biol 238: 1-12.
4. Maeshima A, Zhang YQ, Furukawa M, Naruse T, Kojima I (2000) Hepatocyte growth factor induces branching tubulogenesis by modulating the activin-follistatin system. Kid Int 58: 1511-1522.
5. Pepper S (1997) Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Fact Rev 8: 21-43.
6. Maeshima K, Maeshima A, Hayashi Y, Kishi S, Kojima I (2004) Crucial role of activin A in tubulogenesis of endothelial cells induced by vascular endothelial growth factor. Endocrinology 145: 3739-3745.
7. Poulaki V, Mitsiades N, Kruse FE, Radetzky S, Iliaki E, Kirchhof B, Joussen AM (2004) Activin A in the regulation of corneal neovasculization and vascular endothelial growth factor expression. Am J Pathol 164: 1293-1302.
8. Breit SB, Ashman K, Wilting J, Rossler J, Hatzi E, Fitsis T, Schweigerer L (2000) The N-myc oncogene in human neuroblastoma cells: downregulation of an angiogenesis inhibitor identified as activin A. Cancer Res 60: 4596-4601.
9. Kojima I, Mogami H, Kawamura N, Yasuda H, Shibata H (1993) Modulation of growth of vascular smooth muscle cells by activin A. Exp Cell Res 206: 152-156.
10. Pawlowski JE, Taylor DS, Valentine M, Hail M, Ferrer P, Kowala MC (1997) Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. J Clin Invest 100: 639-648.
11. Engelse MA, Neele JM, van Achteberg TAE, van Aken BE, van Schaik RHN, Pannekoek H, de Vries CJM (1999) Human activin A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells. Cir Res 85: 931-939.
12. Gospodarowicz D (1991) Biological activities of fibroblast growth factor. Ann NY Acad Sci 638: 1-8.
13. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83: 7292-7301.
14. Lindner V, Majack RA, Reidy MA (1990) Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest 85: 2004-2008.
15. Iwakura A, Fujita M, Kataoka K, Tambara K, Sakakibara Y, Komeda M, Tabata Y (2003) Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 18: 93-99.
16. Bao YL, Tsuchida K, Liu B, Kurisaki A, Matsuzaki T, Sugino H (2005) Synergic activity of activin A and basic fibroblast growth factor on tyrosine hydroxylase expression through Smad3 and ERK1/ERK2 signaling pathways. J Endocrinol 189: 409-421.
17. Cao Y, Hong A, Schulten H, Post MJ (2005) Update on therapeutic neovasculization. Cardiovas Res 65: 639-648.
18. Yamada S, Yamamoto Y, Nagasawa M, Hara A, Kodera T, Kojima I (2006) In vitro transdifferentiation of mature hepatocytes into insulin-producing cells. Endocrine J 53: 789-795.
19. Carmeliet P (2003) Angiogenesis in health and disease. Nature Med 9: 653-660.
20. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425: 577-584.
21. Yu L, Hebert MC, Zhang YE (2002) TGF-β receptor-activated MAP kinase mediated Smad-independent TGF-β responses. EMBO J 21: 3749-3759.